1. Product Overview & Specifications

2. Key Applications

Biomedical Research

Demonstrates superior anti-epileptic activity compared to L-leucine, effectively terminating seizure activity without sedative effects in preclinical models.

Pharmaceutical Development

Used in chiral drug synthesis and as a building block for peptide-based therapeutics targeting neurological disorders.

Biochemical Studies

Critical for protein structure-function analysis and enzyme-substrate interaction studies due to its stereospecific properties.

3. Usage Scenarios

In Vitro Neuroprotection Studies

Applied at 10-100 μM concentrations to modulate neuronal receptor activity while maintaining basal synaptic transmission.

Epilepsy Model Systems

Administered in rodent models at 50 mg/kg doses, showing comparable efficacy to diazepam in seizure suppression.

4. Client Case Studies

Neuropharma Research Institute

Implemented D-Leucine in high-throughput screening of novel antiepileptic agents, achieving 40% faster lead compound identification.

Biotech Peptide Solutions

Utilized in chiral peptide synthesis for blood-brain barrier penetrating therapeutics, improving product purity by 15%.

5. Technical Inquiry